Bryant Summers | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Bryant Summers
The Ohio State University

Bryant Summers
Affiliation The Ohio State University
Country United States
Scopus ID 56339860000
Documents 12
Citations 89
h-index 5
Subject Area Medicine and Health Sciences
Event International PopularScientist Awards

Bryant Summers is a researcher affiliated with The Ohio State University whose supplied bibliometric profile places the work within Medicine and Health Sciences. The profile records 12 documents, 89 citations, and an h-index of 5. These indicators provide a quantitative description of the supplied publication record and can be considered alongside publication topics, scholarly contributions, and the relevance of individual research outputs. The recognition context is the International PopularScientist Awards.

Abstract

Bryant Summers is presented in the supplied recognition profile as a Medicine and Health Sciences researcher affiliated with The Ohio State University in the United States. The supplied Scopus identification number is 56339860000, with a reported publication record of 12 documents, 89 citations, and an h-index of 5. These bibliometric measures provide a concise quantitative view of the research record. The supplied publication information also identifies scholarship concerning kidney-function estimation and medication-related decision-making as part of the broader evidence base relevant to contemporary clinical pharmacy and health sciences research.

Keywords

  • Medicine and Health Sciences
  • Clinical Pharmacy
  • Kidney Function
  • Estimated Glomerular Filtration Rate
  • Medication-Related Decision-Making
  • Research Impact
  • Bibliometrics

Introduction

Research in medicine and health sciences frequently connects clinical evidence, pharmacotherapy, kidney function assessment, and methods for supporting treatment decisions. One supplied publication associated with this research context is the 2026 article titled “Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.” The article was published in the Journal of the American College of Clinical Pharmacy, volume 9, issue 2, as article e70153. [2]

Research Profile

The supplied researcher profile identifies Bryant Summers with The Ohio State University and places the research activity in Medicine and Health Sciences. The reported Scopus identifier is 56339860000. The supplied bibliometric figures are 12 documents, 89 citations, and an h-index of 5. Scopus author identifiers and bibliometric indicators are useful for distinguishing an author’s indexed publication record and summarizing citation activity, although such indicators represent only selected quantitative dimensions of scholarly work. [1]

Research Contributions

The supplied publication title identifies a research discussion focused on estimated glomerular filtration rate and medication-related decision-making. The associated article describes the transition toward race-free eGFR approaches and considers how contemporary kidney-function assessment can be incorporated into clinical pharmacy practice. [2] The topic is relevant to medication dosing, renal function assessment, clinical decision support, and the development of standardized healthcare practices.

Publications

The supplied publication material includes a 2026 article concerning race-free estimated glomerular filtration rate and medication-related decision-making. The article is identified in the journal record as a review and opinion contribution associated with the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. [2]

  • Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Journal of the American College of Clinical Pharmacy, 9(2), e70153.

Research Impact

The supplied bibliometric profile reports 89 citations across 12 documents and an h-index of 5. These figures indicate that the indexed publication record has accumulated measurable citation activity. [1] Bibliometric indicators should be interpreted in relation to field-specific publication practices, database coverage, authorship patterns, publication age, and the qualitative significance of individual contributions.

Award Suitability

The supplied profile contains several documented elements that can be considered in an academic recognition review, including an institutional affiliation, a Scopus author identifier, publication and citation metrics, and a defined subject area. The publication material supplied for this profile also demonstrates engagement with a contemporary clinical topic involving renal function estimation and medication-related decision-making.

Conclusion

Bryant Summers is presented in the supplied profile as a Medicine and Health Sciences researcher affiliated with The Ohio State University. The reported record comprises 12 documents, 89 citations, and an h-index of 5, with Scopus Author ID 56339860000. The supplied publication context concerns kidney-function estimation and medication-related decision-making, including contemporary discussion of race-free estimated glomerular filtration rate and its implementation in clinical pharmacy practice. [1] [2]

References

  1. Elsevier. (n.d.). Scopus author details: Bryant Summers, Author ID 56339860000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56339860000
  2. Wallace, J. L., Rungkitwattanakul, D., Khan, R. W., Anderson, L., Anderson, E. R., El Nekidy, W. S., Nemecek, B. D., Meaney, C. J., Prasad-Reddy, L., Salama, L., Hudson, J. Q., Kane-Gill, S. L., Barreto, E. F., Bzowyckyj, A. S., & St. Peter, W. (2026). Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Journal of the American College of Clinical Pharmacy, 9(2), e70153.
    https://doi.org/10.1002/jac5.70153
  3. Pierce, D., Brokhof, M. M., Fredrick, S. R., et al. (2026). Comment on “Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.” Journal of the American College of Clinical Pharmacy.
    https://doi.org/10.1002/jac5.70201
  4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4S), S117–S314.
    https://doi.org/10.1016/j.kint.2023.10.018
  5. St. Peter, W. L., Bzowyckyj, A. S., Anderson-Haag, T., et al. (2024). Moving Forward From Cockcroft-Gault Creatinine Clearance to Race-Free Estimated Glomerular Filtration Rate to Improve Medication-Related Decision-Making in Adults Across Healthcare Settings. American Journal of Health-System Pharmacy, 82, zxae317.
    https://doi.org/10.1093/ajhp/zxae317

Adnan Said | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Adnan Said
University of Wisconsin School of Medicine and Public Health

Adnan Said
Affiliation University of Wisconsin School of Medicine and Public Health
Country United States
Scopus Id 35582909600
Documents 107
Citation 5,510
h-index 35
Subject Area Medicine
Event International Popular Scientist Awards
Orcid 0000-0001-9944-4071

Adnan Said is a medicine researcher affiliated with the University of Wisconsin School of Medicine and Public Health in the United States. The researcher profile supplied for this article lists 107 documents, 5,510 citations, and an h-index of 35 in Scopus, with research activity represented across hepatology, interventional radiology, liver transplantation, portal hypertension, and related clinical and translational areas. The publication record includes collaborative studies addressing transjugular intrahepatic portosystemic shunt (TIPS) procedures, gastrointestinal bleeding, liver fibrosis, and transplantation. [1]

Abstract

This academic recognition profile presents the research record of Adnan Said, whose supplied Scopus profile contains 107 documents, 5,510 citations, and an h-index of 35. His publication contributions represented in the supplied record focus substantially on liver-related clinical research, including portal hypertension, TIPS, gastrointestinal bleeding, liver transplantation, hepatic fibrosis, and associated diagnostic and therapeutic questions. The listed publications also demonstrate collaboration across multidisciplinary research groups involving hepatology, interventional radiology, transplantation, nuclear medicine, and related clinical sciences. [1]

Keywords

Adnan Said; Medicine; Hepatology; Liver Disease; Portal Hypertension; TIPS; Liver Transplantation; Gastrointestinal Bleeding; Liver Fibrosis; Interventional Radiology; Clinical Research; Translational Medicine; Research Impact.

Introduction

Research in hepatology and liver medicine encompasses complex interactions between chronic liver disease, portal hypertension, transplantation, vascular interventions, and complications such as gastrointestinal bleeding. Contemporary clinical investigation in these areas frequently combines patient outcomes, procedural variables, diagnostic imaging, and translational approaches. The publications supplied for this profile place Adnan Said within this multidisciplinary research environment, with several studies examining outcomes associated with TIPS and liver transplantation. [2]

Research Profile

The supplied bibliometric information identifies Adnan Said as a medicine researcher with a Scopus author identifier of 35582909600. The stated profile includes 107 documents, 5,510 citations, and an h-index of 35. These indicators describe the publication and citation record supplied for this recognition page and should be interpreted in the context of the coverage, indexing practices, author-disambiguation procedures, and update timing of the relevant database. [1]

The supplied publications demonstrate substantial collaborative authorship. The listed studies involve investigators from different clinical and research specialties and include multi-author ALTA Group investigations. Such collaboration is particularly relevant to complex liver-care research, where procedural outcomes, patient characteristics, imaging, transplantation, and clinical management may require integrated expertise.

Research Contributions

The supplied publications identify several recurring research themes. One area concerns outcomes following TIPS, a procedure used in the management of selected complications of portal hypertension. A 2025 ALTA Group study examined portal hypertensive gastropathy and MELD-Na score in relation to recurrent gastrointestinal bleeding after TIPS. [1]

Another contribution concerns changes in platelet count following TIPS creation. The 2023 study was conducted by the ALTA Group and investigated platelet-count changes after the procedure, contributing to the broader evaluation of physiological and clinical outcomes associated with TIPS. [2]

Publications

The following publications are drawn from the supplied Crossref-indexed publication information and represent selected research contributions associated with Adnan Said.

  1. Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Alimentary Pharmacology & Therapeutics.
  2. Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study. Journal of Vascular and Interventional Radiology.
  3. The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study. Hepatology.
  4. Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor Positron Emission Tomography in a Human-sized Swine Model. Journal of Nuclear Medicine.
  5. Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report. Transplant Infectious Disease.

Research Impact

The supplied Scopus metrics of 5,510 citations and an h-index of 35 provide bibliometric measures of the visibility and citation history associated with the identified author profile. [1] Bibliometric indicators are quantitative measures and do not independently establish the clinical effectiveness, methodological quality, or practical significance of individual studies.

Within the supplied publication sample, the research addresses clinically relevant questions concerning TIPS, portal hypertension, gastrointestinal bleeding, hemodynamic factors, liver fibrosis imaging, and transplantation. The combination of clinical studies, collaborative group research, and translational investigation indicates engagement with multiple dimensions of liver medicine. [1] [2] [3] [4] [5]

Award Suitability

For the purposes of the International Popular Scientist Awards, the supplied record provides several documented elements relevant to an academic recognition profile: a substantial indexed publication record, reported citation activity, an h-index of 35, and research contributions in medicine. The selected publications demonstrate work in liver-related clinical and translational research, including TIPS outcomes, portal hypertension, liver fibrosis imaging, and transplantation. [1]–[5]

Conclusion

Adnan Said’s supplied academic profile represents a research portfolio in medicine with notable emphasis on hepatology, liver-related interventions, transplantation, portal hypertension, and translational imaging. The stated Scopus record comprises 107 documents, 5,510 citations, and an h-index of 35. The selected publications further document participation in collaborative investigations addressing TIPS outcomes, gastrointestinal bleeding, platelet changes, hemodynamics, liver fibrosis, and transplantation. [1]–[5]

References

  1. Hu, K.; Sedki, M.; Kwong, A.; Kesselman, A.; Kolli, K. P.; Morelli, G.; Spengler, E.; Said, A.; Lai, J.; Desai, A.; et al. (2025). Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Alimentary Pharmacology & Therapeutics.
    https://doi.org/10.1111/apt.18362
  2. Wong, R. J.; Ge, J.; Boike, J.; German, M.; Morelli, G.; Spengler, E.; Said, A.; Desai, A.; Couri, T.; Paul, S.; et al. (2023). Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study. Journal of Vascular and Interventional Radiology.
    https://doi.org/10.1016/j.jvir.2023.04.015
  3. Bommena, S.; Mahmud, N.; Boike, J. R.; Thornburg, B. G.; Kolli, K. P.; Lai, J. C.; German, M.; Morelli, G.; Spengler, E.; Said, A.; et al. (2023). The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study. Hepatology.
    https://doi.org/10.1097/HEP.0000000000000283
  4. Pirasteh, A.; Periyasamy, S.; Meudt, J. J.; Lui, Y.; Lee, L. M.; Schachtschneider, K. M.; Schook, L. B.; Gaba, R. C.; Mao, L.; Said, A.; et al. (2022). Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor Positron Emission Tomography in a Human-sized Swine Model. Journal of Nuclear Medicine.
    https://doi.org/10.2967/jnumed.121.263736
  5. Said, A.; Weiss, M.; Varhelyi, A.; Farago, R.; Ballweg, C.; Rice, J.; Agarwal, P.; Fernandez, L.; Foley, D. (2021). Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report. Transplant Infectious Disease.
    https://doi.org/10.1111/tid.13466
  6. Elsevier. (n.d.). Scopus author details: Adnan Said, Author ID 35582909600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35582909600